Cyclooxygenase inhibition in sepsis: Is there life after death?

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Aronoff, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; LORNOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; DISEASE SEVERITY; ENZYME INHIBITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMATIC REVIEW; ANIMAL; IMMUNOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; CYCLOOXYGENASE INHIBITORS; HUMANS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84862297396     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/696897     Document Type: Review

References (78)

1. Chalupka A. N., Talmor D., The economics of sepsis Critical Care Clinics 2012 28 57 76
2. Lever A., Mackenzie I., Sepsis: definition, epidemiology, and diagnosis British Medical Journal 2007 335 7625 879 883 (Pubitemid 350069465)
3. Hinshaw L. B., Solomon L. A., Erds E. G., Reins D. A., Gunter B. J., Effects of acetylsalicylic acid on the canine response to endotoxin Journal of Pharmacology and Experimental Therapeutics 1967 157 3 665 671
4. Northover B. J., Subramanian G., Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs Journal of Pathology Bacteriology 1962 83 463 468
5. Adams T. Jr., Traber D. L., The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep Circulatory Shock 1982 9 5 481 489 (Pubitemid 12001326)
6. Akbulut H., Celik I., Ayar A., Vural P., Canbaz M., Ibuprofen reduces plasma nitrite/nitrate levels in a rabbit model of endotoxin-induced shock Neuroendocrinology Letters 2005 26 4 407 412 (Pubitemid 41518786)
7. Almqvist P. M., Ekstrom B., Kuenzig M., Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen Circulatory Shock 1984 14 2 129 136 (Pubitemid 14015820)
8. Azab A., Kobal S., Rubin M., Kaplanski J., Inhibition of prostaglandins does not reduce the cardiovascular changes during endotoxemia in rats Prostaglandins Leukotrienes and Essential Fatty Acids 2006 74 2 135 142 (Pubitemid 43082138)
9. Bahr T., Schaper U., Becker K., Lueddeckens G., Forster W., Scheuch D. W., Grupe R., Gores E., Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models Biomedica Biochimica Acta 1988 47 10-11 S289 S292
10. Beck R. R., Abel F. L., Papadakis E., Influence of ibuprofen on renal function in acutely endotoxemic dogs Circulatory Shock 1989 28 1 37 47 (Pubitemid 19140651)
11. Celik I., Akbulut A., Kilic S. S., Rahman A., Vural P., Canbaz M., Felek S., Effects of ibuprofen on the physiology and outcome of rabbit endotoxic shock BMC Infectious Diseases 2002 2, article 26
12. Ejima K., Layne M. D., Carvajal I. M., Kritek P. A., Baron R. M., Chen Y. H., Vom Saal J., Levy B. D., Yet S. F., Perrella M. A., Cyclooxygenase-2- deficient mice are resistant to endotoxin-induced inflammation and death The FASEB Journal 2003 17 10 1325 1327
13. Erds E. G., Hinshaw L. B., Gill C. C., Effect of indomethacin in endotoxin shock in the dog Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 1967 125 3 916 919
14. Etienne A., Hecquet F., Soulard C., Touvay C., Clostre F., Braquet P., The relative role of PAF-acether and icosanoids in septic shock Pharmacological Research Communications 1988 18 supplement 71 79 (Pubitemid 16030340)
15. Ferluga J., Kaplun A., Allison A. C., Protection of mice against endotoxin-induced liver damage by anti-inflammatory drugs Agents and Actions 1979 9 5-6 566 574 (Pubitemid 10152367)
16. Fink M. P., Morrissey P. E., Stein K. L., Clement R. E., Fiallo V., Gardiner W. M., Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits Circulatory Shock 1988 26 1 41 57
17. Fink M. P., Rothschild H. R., Deniz Y. F., Wang H., Lee P. C., Cohn S. M., Systemic and mesenteric O2 metabolism in endotoxic pigs: effect of ibuprofen and meclofenamate Journal of Applied Physiology 1989 67 5 1950 1957 (Pubitemid 20039405)
18. Fink M. P., Kaups K. L., Wang H., Rothschild H. R., Ibuprofen improves survival but does not ameliorate increased gut mucosal permeability in endotoxic pigs Archives of Surgery 1992 127 1 49 54
19. Fletcher J. R., Herman C. M., Ramwell P. W., Improved survival in endotoxemia with aspirin and indomethacin pretreatment Surgical Forum 1976 27 11 12 (Pubitemid 8006779)
20. Fletcher J. R., Ramwell P. W., Lidocaine or indomethacin improves survival in baboon endotoxin shock Journal of Surgical Research 1978 24 3 154 160 (Pubitemid 8317124)
21. Fletcher J. R., Ramwell P. W., Indomethacin improves survival after endotoxin in baboons Advances in Prostaglandin and Thromboxane Research 1980 7 821 828
22. Furtado N., Beier U. H., Gorla S. R., Fornell L., Lumpaopong A., Radhakrishnan J., John E., The effect of indomethacin on systemic and renal hemodynamics in neonatal piglets during experimental endotoxemia Pediatric Surgery International 2008 24 8 907 911
23. Goto F., Fujita T., Otani E., Yamamuro M., The effect of indomethacin and adrenergic receptor blocking agents on rats and canine responses to endotoxin Circulatory Shock 1980 7 4 413 424 (Pubitemid 11213074)
24. Goto M., Griffin A. J., Indomethacin treatment in newborn canine endotoxic shock Japanese Heart Journal 1991 32 3 381 390
25. Hagmann W., Denzlinger C., Keppler D., Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action Circulatory Shock 1984 14 4 223 235 (Pubitemid 15220530)
26. Hall R. C., Hodge R. L., Irvine R., Katic F., Middleton J. M., The effect of aspirin on the response to endotoxin The Australian Journal of Experimental Biology and Medical Science 1972 50 5 589 601
27. Halushka P. V., Wise W. C., Cook J. A., Protective aspects of aspirin in endotoxic shock Journal of Pharmacology and Experimental Therapeutics 1981 218 2 464 469 (Pubitemid 11044124)
28. Hcherl K., Schmidt C., Kurt B., Bucher M., Activation of the PGI2/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock Hypertension 2008 52 2 330 335
29. Jacobs E. R., Soulsby M. E., Bone R. C., Wilson F. J. Jr., Hiller F. C., Ibuprofen in canine endotoxin shock The Journal of Clinical Investigation 1982 70 536 541 (Pubitemid 12054577)
30. Leach M., Hamilton L. C., Olbrich A., Wray G. M., Thiemermann C., Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone British Journal of Pharmacology 1998 124 3 586 592 (Pubitemid 28254517)
31. Parratt J. R., Sturgess R., The effect of indomethacin on the cardiovascular responses of cats to E. coli endotoxin British Journal of Pharmacology 1973 49 1 163P 164P
32. Parratt J. R., Sturgess R. M., The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat British Journal of Pharmacology 1974 50 2 177 183
33. Parratt J. R., Sturgess R. M., E. coli endotoxin shock in the cat: treatment with indomethacin British Journal of Pharmacology 1975 53 4 485 488
34. Peevy K. J., Ronnlund R. D., Chartrand S. A., Boerth R. C., Longenecker G. L., Ibuprofen in experimental Group B streptococcal shock Circulatory Shock 1988 24 1 35 41 (Pubitemid 18038007)
35. Pettipher E. R., Wimberly D. J., Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock Cytokine 1994 6 5 500 503 (Pubitemid 24306964)
36. Rao P. S., Cavanagh D., Gaston L. W., Endotoxic shock in the primate: effects of aspirin and dipyridamole administration American Journal of Obstetrics and Gynecology 1981 140 8 914 922 (Pubitemid 11061679)
37. Reddy R. C., Chen G. H., Tateda K., Tsai W. C., Phare S. M., Mancuso P., Peters-Golden M., Standiford T. J., Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis American Journal of Physiology 2001 281 3 L537 L543
38. Reichgott M. J., Engelman K., Indomethacin: lack of effect on lethality of endotoxin in rats Circulatory Shock 1975 2 3 215 219
39. Schaper U., Lueddeckens G., Forster W., Scheuch D. W., Inhibition of lipoxygenase (LOX) or of cyclooxygenase (COX) improves survival of rats in endotoxin shock Biomedica Biochimica Acta 1988 47 10-11 S282 S285
40. Schrauwen E., Vandeplassche G., Laekeman G., Houvenaghel A., Endotoxic shock in the piglet: beneficial effects of prostaglandin synthesis inhibition Prostaglandins Leukotrienes and Medicine 1984 13 3 271 278 (Pubitemid 14162515)
41. Soulsby M. E., Jacobs E. R., Perlmutter B. H., Bone R. C., Protection of myocardial function during endotoxin shock by ibuprofen Prostaglandins Leukotrienes and Medicine 1984 13 3 295 305 (Pubitemid 14162519)
42. Tariq M., Effect of some new prostaglandin synthetase inhibitors on the endotoxin induced mortality and biochemical changes in experimental animals Research Communications in Chemical Pathology and Pharmacology 1988 60 19 25
43. Toth P. D., Hamburger S. A., Hastings G. H., Judy W. V., Benoxaprofen attenuation of lethal canine endotoxic shock Circulatory Shock 1985 15 2 89 103 (Pubitemid 15126553)
44. Tuntan B., Altug S., Uludag O., Demirkay B., Abacioglu N., Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis Pharmacological Research 2003 48 1 37 48 (Pubitemid 36603360)
45. Wise W. C., Cook J. A., Eller T., Halushka P. V., Ibuprofen improves survival from endotoxic shock in the rat Journal of Pharmacology and Experimental Therapeutics 1980 215 1 160 164 (Pubitemid 11102269)
46. Kahlke V., Seidel M., Stapela S., Brotzmann K., Schafmayer C., Schroder J., Inhibition of cyclooxygenase-2 by NS-398 following hemorrhage and subsequent sepsis: no beneficial effects in either gender Surgical Infections 2004 5 29 37 (Pubitemid 38745053)
47. Ngel S. C., Chada M., Schmidt A. M., Bosselmann S., Kandler M., Schweer H., Watzer B., Schneider H., Gessner A., Rascher W., Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis Prostaglandins and Other Lipid Mediators 2009 90 1-2 7 12
48. Bone R. C., Jacobs E. R., Wilson F. J. Jr., Increased hemodynamic and survival with endotoxin and septic shock with ibuprofen treatment Progress in Clinical and Biological Research 1987 236 327 332
49. Butler R. R. Jr., Wise W. C., Halushka P. V., Cook J. A., Gentamicin and indomethacin in the treatment of septic shock: effects on prostacyclin and thromboxane A2 production Journal of Pharmacology and Experimental Therapeutics 1983 225 1 94 101 (Pubitemid 13137008)
50. Culp J. R., Erds E. G., Hinshaw I. B., Holmes D. D., Effects of anti-inflammatory drugs in shock caused by injection of living E. coli cells Proceedings of the Society for Experimental Biology and Medicine 1971 137 1 219 223
51. Fink M. P., MacVittie T. J., Casey L. C., Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis Annals of Surgery 1984 200 5 619 626 (Pubitemid 15206042)
52. Fox G. A., Paterson N. A. M., McCormack D. G., Rohan M., Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis Journal of Cardiovascular Pharmacology 1996 28 1 30 35 (Pubitemid 26190452)
53. Fredenburgh L. E., Velandia M. M., Ma J., Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis The Journal of Immunology 2011 187 5255 5267
54. Goldmann O., Hertzén E., Hecht A., Schmidt H., Lehne S., Norrby-Teglund A., Medina E., Inducible cyclooxygenase released prostaglandin E 2 modulates the severity of infection caused by Streptococcus pyogenes The Journal of Immunology 2010 185 4 2372 2381
55. Lee Y. J., Chuang Y. C., Ibuprofen augments pro-inflammatory cytokine release in a mouse model of Vibrio vulnificus infection Microbiology and Immunology 2010 54 9 542 550
56. Runkle B., Goldberg R. N., Streitfeld M. M., Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2 Pediatric Research 1984 18 9 874 878 (Pubitemid 14072418)
57. Short B. L., Gardiner M., Walker R. I., Jones S. R., Fletcher J. R., Indomethacin improves survival in gram-negative sepsis Advances in Shock Research 1981 6 27 36
58. Short B. L., Miller M. K., Fletcher J. R., Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs Pediatrics 1982 70 3 343 347 (Pubitemid 12052273)
59. Short B. L., Miller M. K., Pan J., Group B streptococcal (GBSS) newborn septic shock model: the role of prostaglandins Progress in Clinical and Biological Research 1988 264 333 336
60. Mack Strong V. E., Mackrell P. J., Concannon E. M., Naama H. A., Schaefer P. A., Shaftan G. W., Stapleton P. P., Daly J. M., Blocking prostaglandin E 2 after trauma attenuates pro-inflammatory cytokines and improves survival Shock 2000 14 3 374 379
61. Wise W. C., Halushka P. V., Knapp R. G., Cook J. A., Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock Circulatory Shock 1985 17 1 59 71 (Pubitemid 16247159)
62. Bernard G. R., Wheeler A. P., Russell J. A., Schein R., Summer W. R., Steinberg K. P., Fulkerson W. J., Wright P. E., Christman B. W., Dupont W. D., Higgins S. B., Swindell B. B., The effects of ibuprofen on the physiology and survival of patients with sepsis The New England Journal of Medicine 1997 336 13 912 918 (Pubitemid 27137191)
63. Haupt M. T., Jastremski M. S., Clemmer T. P., Metz C. A., Goris G. B., Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study Critical Care Medicine 1991 19 11 1339 1347
64. Memi D., Karamanlioglu B., Turan A., Koyuncu O., Pamuku Z., Effects of lornoxicam on the physiology of severe sepsis Critical Care 2004 8 6 R474 482
65. Arons M. M., Wheeler A. P., Bernard G. R., Christman B. W., Russell J. A., Schein R., Summer W. R., Steinberg K. P., Fulkerson W., Wright P., Dupont W. D., Swindell B. B., Drummond A., Pena M., DeBoisblanc B., Everett B., Glenn C., Tebbe D., Carmichael L. C., Stroud M. J., Higgins S. B., Jiang K., Plummer W. D., Carroll F. E., Hudson L. D., Anardi D., Abernathy M. J., Mallatratt L., Weston P., Wright P. E., Colvin K., Effects of ibuprofen on the physiology and survival of hypothermic sepsis Critical Care Medicine 1999 27 4 699 707 (Pubitemid 29218201)
66. Metz C. A., Sheagren J. N., Ibuprofen in animal models of septic shock Journal of Critical Care 1990 5 3 206 212 (Pubitemid 20330490)
67. Aronoff D. M., Peres C. M., Serezani C. H., Ballinger M. N., Carstens J. K., Coleman N., Moore B. B., Peebles R. S., Faccioli L. H., Peters-Golden M., Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities The Journal of Immunology 2007 178 3 1628 1634 (Pubitemid 46154634)
68. Ballinger M. N., McMillan T. R., Moore B. B., Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation Archivum Immunologiae et Therapiae Experimentalis 2007 55 1 1 12 (Pubitemid 46294890)
69. Stables M. J., Newson J., Ayoub S. S., Brown J., Hyams C. J., Gilroy D. W., Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria Blood 2010 116 16 2950 2959
70. Kalinski P., Regulation of immune responses by prostaglandin E 2 The Journal of Immunology 2012 188 21 28
71. Fletcher J. R., Ramwell P. W., Indomethacin treatment following baboon endotoxin shock improves survival Advances in Shock Research 1980 4 103 111
72. Fink M. P., Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis Journal of Antimicrobial Chemotherapy 1998 41 supplement 81 94 (Pubitemid 28062148)
73. Reines H. D., Halushka P. V., Olanoff L. S., Hunt P. S., Dazoxiben in human sepsis and adult respiratory distress syndrome Clinical Pharmacology and Therapeutics 1985 37 4 391 395 (Pubitemid 15238883)
74. Leeman M., Boeynaems J. M., Degaute J. P., Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome Chest 1985 87 6 726 730 (Pubitemid 15063770)
75. Ball H. A., Cook J. A., Wise W. C., Halushka P. V., Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock Intensive Care Medicine 1986 12 3 116 126 (Pubitemid 16118205)
76. Aronoff D. M., Canetti C., Peters-Golden M., Prostaglandin E 2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP The Journal of Immunology 2004 173 1 559 565 (Pubitemid 38797384)
77. Aronoff D. M., Lewis C., Serezani C. H., Eaton K. A., Goel D., Phipps J. C., Peters-Golden M., Mancuso P., E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection The Journal of Immunology 2009 183 4 2642 2649
78. Sadikot R. T., Zeng H., Azim A. C., Joo M., Dey S. K., Beyer R. M., Pebbles R. S., Blackwell T. S., Christman J. W., Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibtion of COX-2 European Journal of Immunology 2007 37 4 1001 1009 (Pubitemid 46925337)